rs35186399

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001928.4(CFD):​c.205G>A​(p.Glu69Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00886 in 1,565,868 control chromosomes in the GnomAD database, including 84 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0066 ( 11 hom., cov: 31)
Exomes 𝑓: 0.0091 ( 73 hom. )

Consequence

CFD
NM_001928.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.65

Publications

13 publications found
Variant links:
Genes affected
CFD (HGNC:2771): (complement factor D) This gene encodes a member of the S1, or chymotrypsin, family of serine peptidases. This protease catalyzes the cleavage of factor B, the rate-limiting step of the alternative pathway of complement activation. This protein also functions as an adipokine, a cell signaling protein secreted by adipocytes, which regulates insulin secretion in mice. Mutations in this gene underlie complement factor D deficiency, which is associated with recurrent bacterial meningitis infections in human patients. Alternative splicing of this gene results in multiple transcript variants. At least one of these variants encodes a preproprotein that is proteolytically processed to generate the mature protease. [provided by RefSeq, Nov 2015]
CFD Gene-Disease associations (from GenCC):
  • recurrent Neisseria infections due to factor D deficiency
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004876882).
BP6
Variant 19-860766-G-A is Benign according to our data. Variant chr19-860766-G-A is described in ClinVar as Benign. ClinVar VariationId is 1165412.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00659 (1001/152006) while in subpopulation NFE AF = 0.0101 (687/67884). AF 95% confidence interval is 0.00949. There are 11 homozygotes in GnomAd4. There are 469 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CFDNM_001928.4 linkc.205G>A p.Glu69Lys missense_variant Exon 2 of 5 ENST00000327726.11 NP_001919.2 P00746
CFDNM_001317335.2 linkc.226G>A p.Glu76Lys missense_variant Exon 2 of 5 NP_001304264.1 P00746K7ERG9A6XNE2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CFDENST00000327726.11 linkc.205G>A p.Glu69Lys missense_variant Exon 2 of 5 1 NM_001928.4 ENSP00000332139.4 P00746

Frequencies

GnomAD3 genomes
AF:
0.00659
AC:
1001
AN:
151890
Hom.:
11
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00210
Gnomad AMI
AF:
0.0747
Gnomad AMR
AF:
0.00269
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00982
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0101
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00538
AC:
923
AN:
171718
AF XY:
0.00545
show subpopulations
Gnomad AFR exome
AF:
0.00135
Gnomad AMR exome
AF:
0.00142
Gnomad ASJ exome
AF:
0.00317
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00839
Gnomad NFE exome
AF:
0.0100
Gnomad OTH exome
AF:
0.00817
GnomAD4 exome
AF:
0.00911
AC:
12879
AN:
1413862
Hom.:
73
Cov.:
31
AF XY:
0.00876
AC XY:
6143
AN XY:
700986
show subpopulations
African (AFR)
AF:
0.00138
AC:
45
AN:
32514
American (AMR)
AF:
0.00149
AC:
60
AN:
40158
Ashkenazi Jewish (ASJ)
AF:
0.00295
AC:
75
AN:
25426
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37650
South Asian (SAS)
AF:
0.000267
AC:
22
AN:
82486
European-Finnish (FIN)
AF:
0.00857
AC:
305
AN:
35572
Middle Eastern (MID)
AF:
0.00186
AC:
8
AN:
4298
European-Non Finnish (NFE)
AF:
0.0110
AC:
12016
AN:
1096940
Other (OTH)
AF:
0.00592
AC:
348
AN:
58818
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
835
1670
2504
3339
4174
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00659
AC:
1001
AN:
152006
Hom.:
11
Cov.:
31
AF XY:
0.00631
AC XY:
469
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.00210
AC:
87
AN:
41488
American (AMR)
AF:
0.00268
AC:
41
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00982
AC:
104
AN:
10586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0101
AC:
687
AN:
67884
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
52
104
155
207
259
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00681
Hom.:
1
Bravo
AF:
0.00626
TwinsUK
AF:
0.00998
AC:
37
ALSPAC
AF:
0.00960
AC:
37
ESP6500AA
AF:
0.00135
AC:
5
ESP6500EA
AF:
0.00756
AC:
56
ExAC
AF:
0.00475
AC:
526

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CFD: BS1, BS2 -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

CFD-related disorder Benign:1
May 23, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
20
DANN
Benign
0.96
DEOGEN2
Benign
0.32
T;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.92
FATHMM_MKL
Benign
0.48
N
LIST_S2
Benign
0.40
T;T
MetaRNN
Benign
0.0049
T;T
MetaSVM
Benign
-0.76
T
MutationAssessor
Benign
-0.43
N;.
PhyloP100
1.6
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-0.96
N;.
REVEL
Benign
0.20
Sift
Benign
0.24
T;.
Sift4G
Benign
0.84
T;T
Polyphen
0.14
B;.
Vest4
0.36
MVP
0.72
MPC
0.34
ClinPred
0.0064
T
GERP RS
2.6
Varity_R
0.49
gMVP
0.66
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35186399; hg19: chr19-860766; COSMIC: COSV99708861; COSMIC: COSV99708861; API